000 | 01161 a2200349 4500 | ||
---|---|---|---|
005 | 20250513090532.0 | ||
264 | 0 | _c19960625 | |
008 | 199606s 0 0 eng d | ||
022 | _a0939-5555 | ||
024 | 7 |
_a10.1007/s002770050172 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDe Pauw, B E | |
245 | 0 | 0 |
_aAntibiotic strategy after the empiric phase in patients treated for a hematological malignancy. _h[electronic resource] |
260 |
_bAnnals of hematology _cApr 1996 |
||
300 |
_a273-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeutropenia _xdrug therapy |
700 | 1 | _aDompeling, E C | |
773 | 0 |
_tAnnals of hematology _gvol. 72 _gno. 4 _gp. 273-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002770050172 _zAvailable from publisher's website |
999 |
_c8623428 _d8623428 |